Advances in the Diagnosis and Treatment of Pediatric Hematological Disorders

Pediatric hematology is a dynamic field that largely factors into children's well-being globally, concerning disorders such as leukemia, aplastic anemia, and thalassemia. Traditional diagnostic tools and treatments, although beneficial, face limitations. Concerning hematopoietic stem cell transplantation, complications such as graft-versus-host disease, thrombotic microangiopathy, and impaired graft function persist. Meanwhile, the treatment dynamics for acute lymphoblastic leukemia and acute myeloid leukemia are continuously evolving amid emerging therapeutic targets and medications. Potential in managing transfusion-dependent thalassemia is seen in advancements like gene therapy, presenting new hope. Recent medical technology developments and research herald significant updates in diagnosing and treating these conditions, paving a pathway toward better prognosis and life quality for afflicted children.

This Research Topic aims to unravel recent progress in pediatric hematology, emphasizing advancements in managing complications of pediatric hematopoietic stem cell transplantation, including GVHD, TMA, and poor graft function. Further, it's designed to explore breakthroughs in diagnosing and treating pediatric acute lymphoblastic leukemia, acute myeloid leukemia, aplastic anemia, and the management of transfusion-dependent thalassemia through innovative interventions like gene therapy. The ultimate goal is to offer enriched insights and updated references for researchers and clinicians, fostering the innovation of more precise diagnostic and therapeutic strategies to enhance survival rates and long-term well-being in children.

To gather further insights in pediatric hematological disorder advancements, we invite submissions of Original Research articles, Reviews, Mini-Reviews, and special case reports. We are particularly interested in contributions addressing:

• Advances in diagnosing and managing complications of pediatric hematopoietic stem cell transplantation, such as graft-versus-host disease (GVHD), thrombotic microangiopathy (TMA), and poor graft function.
• Progress in the diagnosis and treatment of pediatric acute lymphoblastic leukemia (ALL).
• New strategies in the diagnosis and management of pediatric acute myeloid leukemia.
• Developments in diagnosing and treating pediatric aplastic anemia.
• Treatment innovations for pediatric transfusion-dependent thalassemia, including gene therapy approaches.

Article types and fees

This Research Topic accepts the following article types, unless otherwise specified in the Research Topic description:

• Brief Research Report
• Case Report
• Classification
• Clinical Trial
• Editorial
• FAIR² Data
• FAIR² DATA Direct Submission
• General Commentary
• Hypothesis and Theory
• ... View all formats

Articles that are accepted for publication by our external editors following rigorous peer review incur a publishing fee charged to Authors, institutions, or funders.

Article types

This Research Topic accepts the following article types, unless otherwise specified in the Research Topic description:

• Brief Research Report
• Case Report
• Classification
• Clinical Trial
• Editorial
• FAIR² Data
• FAIR² DATA Direct Submission
• General Commentary
• Hypothesis and Theory
• Methods
• Mini Review
• Opinion
• Original Research
• Perspective
• Review
• Study Protocol
• Systematic Review
• Technology and Code

Keywords: Pediatric Hematological Disorders Hematopoietic Stem Cell Transplantation Complications Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Aplastic Anemia Transfusion-dependent Thalassemia Gene Therapy

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.